Search

Your search keyword '"Mao, Jun J."' showing total 1,053 results
Start Over Author "Mao, Jun J."
1,053 results on '"Mao, Jun J."'

101. sj-docx-2-ict-10.1177_15347354231162080 – Supplemental material for The Herbal Medicine Suanzaoren (Ziziphi Spinosae Semen) for Sleep Quality Improvements: A Systematic Review and Meta-analysis

Author

Yang, Mingxiao, Wang, Hui, Zhang, Yi Lily, Zhang, Furong, Li, Xiaotong, Kim, Soo-Dam, Chen, Yalan, Chen, Jiyao, Chimonas, Susan, Korenstein, Deborah, and Mao, Jun J.

Subjects
111708 Health and Community Services, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 110306 Endocrinology, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-2-ict-10.1177_15347354231162080 for The Herbal Medicine Suanzaoren (Ziziphi Spinosae Semen) for Sleep Quality Improvements: A Systematic Review and Meta-analysis by Mingxiao Yang, Hui Wang, Yi Lily Zhang, Furong Zhang, Xiaotong Li, Soo-Dam Kim, Yalan Chen, Jiyao Chen, Susan Chimonas, Deborah Korenstein and Jun J. Mao in Integrative Cancer Therapies

Published
2023
Full Text
View/download PDF

102. sj-docx-1-ict-10.1177_15347354231162080 – Supplemental material for The Herbal Medicine Suanzaoren (Ziziphi Spinosae Semen) for Sleep Quality Improvements: A Systematic Review and Meta-analysis

Author

Yang, Mingxiao, Wang, Hui, Zhang, Yi Lily, Zhang, Furong, Li, Xiaotong, Kim, Soo-Dam, Chen, Yalan, Chen, Jiyao, Chimonas, Susan, Korenstein, Deborah, and Mao, Jun J.

Subjects
111708 Health and Community Services, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 110306 Endocrinology, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-1-ict-10.1177_15347354231162080 for The Herbal Medicine Suanzaoren (Ziziphi Spinosae Semen) for Sleep Quality Improvements: A Systematic Review and Meta-analysis by Mingxiao Yang, Hui Wang, Yi Lily Zhang, Furong Zhang, Xiaotong Li, Soo-Dam Kim, Yalan Chen, Jiyao Chen, Susan Chimonas, Deborah Korenstein and Jun J. Mao in Integrative Cancer Therapies

Published
2023
Full Text
View/download PDF

105. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial

Author

Mao, Jun J., Xie, Sharon X., Keefe, John R., Soeller, Irene, Li, Qing S., and Amsterdam, Jay D.

Subjects
Generalized anxiety disorder -- Care and treatment -- Research, German chamomile -- Health aspects -- Research, Herbal medicine -- Health aspects -- Research, Biological sciences, Health, Science and technology
Abstract

ABSTRACT Background: Generalized Anxiety Disorder (GAD) is one of the most common anxiety disorders treated in primary care, yet current therapies have limited efficacy and substantial side effects. Purpose: To [...]

Published
2016
Full Text
View/download PDF

106. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder

Author

Keefe, John R., Mao, Jun J., Soeller, Irene, Li, Qing S., and Amsterdam, Jay D.

Subjects
Generalized anxiety disorder -- Care and treatment, Antianxiety agents, Biological sciences, Health, Science and technology, University of Pennsylvania. Medical Center
Abstract

ABSTRACT Background: Conventional drug treatments for Generalized Anxiety Disorder (GAD) are often accompanied by substantial side effects, dependence, and/or withdrawal syndrome. A prior controlled study of oral chamomile (Matricaria chamomilla [...]

Published
2016
Full Text
View/download PDF

107. Herb-Drug Interactions in Cancer Care

Author

Yeung, K. Simon, Gubili, Jyothirmai, and Mao, Jun J.

Subjects
Cancer -- Risk factors -- Control -- Care and treatment, Cancer recurrence -- Research, Dietary supplements -- Health aspects, Herbs -- Usage -- Health aspects, Chemotherapy, Backup software, Green tea, Medical law, Cancer patients, Drug interactions, Prescriptions (Drugs), Patient education, Cancer prevention, Physicians, Drugs, Tea (Beverage), Health
Abstract

Herbs have served as medicine throughout human history. Since the passage of the Dietary Supplement Health and Education Act (DSHEA), inconsistent regulatory practices have resulted in widespread, indiscriminate use of herbal supplements. Available data indicate that cancer patients use these products (along with standard treatments) more often than the general population. The reasons cited for such use include improving health, reducing the risk of recurrence, and reducing the side effects of cancer treatments. Herbs, however, contain biologically active compounds and can potentially interact with prescription medications, including chemotherapy drugs. We describe the mechanisms via which these interactions may occur, as divided into pharmacokinetics and pharmacodynamics. We highlight four popular herbs and a medicinal mushroom commonly used by cancer patients--turmeric, green tea, ginger, ashwagandha, and reishi mushroom--along with reports of their interactions with standard drugs. We conclude by emphasizing the need to inform patients and physicians about herb-drug interactions and how to advise patients on appropriate use of herbal supplements to minimize the risk for interactions., Introduction Before the era of modern pharmaceuticals, plants were the major source of medicine. Today, herbal products are classified as 'dietary supplements' under the Dietary Supplement Health and Education Act [...]

Published
2018

108. Understanding the Benefits of Acupuncture Treatment for Cancer Pain Management

Author

Deng, Gary, Bao, Ting, and Mao, Jun J.

Subjects
Duloxetine, Cancer pain -- Drug therapy, Pain management, Acupuncture, Radiotherapy, Vincristine, Activities of daily living, State laws, Chemotherapy, Cancer treatment, Nerve compression syndromes, Cancer patients, Bortezomib, Cancer metastasis, Enteritis, Dermatitis, Radiation (Physics), Company business management, Health
Abstract

This article summarizes the current evidence regarding the use of acupuncture for pain management in cancer patients. It includes a description of how acupuncture is thought to work and what the intervention entails, data on acupuncture for managing pain caused by cancer or by cancer treatment (radiation, chemotherapy, endocrine therapy), how acupuncture is practiced in the US medical system, discussion of safety issues, and practical tips on how to integrate acupuncture into cancer care., Introduction Pain is one of the most common, burdensome, and feared symptoms experienced by cancer patients. [1] Common sources of cancer pain can include the cancer itself, such as in [...]

Published
2018

113. Association of Perceived Benefit or Burden of Research Participation With Participants’ Withdrawal From Cancer Clinical Trials

Author

Ulrich, Connie M., primary, Ratcliffe, Sarah J., additional, Zhou, Qiuping, additional, Huang, Liming, additional, Hochheimer, Camille, additional, Gordon, Thomas, additional, Knafl, Kathleen, additional, Miller, Victoria, additional, Naylor, Mary D., additional, Schapira, Marilyn M., additional, Richmond, Therese S., additional, Grady, Christine, additional, and Mao, Jun J., additional

Published
2022
Full Text
View/download PDF

115. A Randomized Placebo Controlled Study of a Plant-Based Dietary Versus Supplement Versus Placebo Intervention in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) Study

Author

Shah, Urvi A., primary, Castro, Francesca, additional, Anuraj, Aishwarya, additional, Schach, Eliana, additional, Derkach, Andriy, additional, Joseph, Nisha S., additional, Adintori, Peter A., additional, Guttentag, Laura, additional, Blaslov, Jenna, additional, Cross, Justin R., additional, Maclachlan, Kylee H., additional, Mailankody, Sham, additional, Korde, Neha, additional, Tan, Carlyn, additional, Hultcrantz, Malin, additional, Hassoun, Hani, additional, Lahoud, Oscar B., additional, Shah, Gunjan L., additional, Scordo, Michael, additional, Peled, Jonathan U., additional, Chung, David J., additional, Landau, Heather, additional, Mao, Jun J., additional, Iyengar, Neil M., additional, Usmani, Saad, additional, Giralt, Sergio A., additional, van den Brink, Marcel R.M., additional, and Lesokhin, Alexander M., additional

Published
2022
Full Text
View/download PDF

116. Microbial Changes in Response to a Plant-Based Diet and/or Supplements in SMM Patients: A National Multi-Arm Randomized Prospective Telehealth Study Via Healthtree: The Nutrition Prevention (NUTRIVENTION-2) Study

Author

Castro, Francesca, primary, Sweeney, Nathan W., additional, Derkach, Andriy, additional, Traore, Kadiatou, additional, Anuraj, Aishwarya, additional, Guttentag, Laura, additional, Blaslov, Jenna, additional, Sahagun, Ana, additional, Hydren, Jay, additional, Chmielewski, Cynthia, additional, Golombick, Terry, additional, Cross, Justin R, additional, Mao, Jun J, additional, van den Brink, Marcel R M, additional, Usmani, Saad, additional, Ahlstrom, Jennifer M., additional, Lesokhin, Alexander M, additional, and Shah, Urvi A, additional

Published
2022
Full Text
View/download PDF

124. COMTVal158Met Affects the Analgesic Response to Acupuncture Among Cancer Survivors With Chronic Pain

Author

Yang, Mingxiao, Baser, Raymond E., Khanin, Raya, Autuori, Isidora, Li, Qing S., Panageas, Katherine S., Orlow, Irene, and Mao, Jun J.

Abstract

Catechol-O-methyltransferase (COMT) is the major enzyme involved in the catabolism of dopamine, a neurotransmitter in the brain’s reward system. The common COMTpolymorphism Val158Met (rs4680 G>A) modulates pain response to opioids through a reward-motivated mechanism; however, its role in nonpharmacological pain medicine has not been clinically characterized. We genotyped 325 participants from a randomized controlled trial of cancer survivors with chronic musculoskeletal pain. We found that carrying methionine at position 158 (158Met) of COMT, encoded by the A allele, significantly increased the analgesic response to electroacupuncture (74% vs 50%; odds ratio [OR]: 2.79; 95% confidence interval [CI]: 1.31, 6.05; P < .01), but not to auricular acupuncture (68% vs 60%; OR: 1.43; 95% CI: .65, 3.12; P = .37) or usual care (24% vs 18%; OR: 1.46; 95% CI: .38, 7.24; P = .61) compared to Val/Val. These findings raise the possibility that COMTVal158Met might be an important predictor of analgesic response to electroacupuncture, providing novel insights into precision nonpharmacologic pain management tailored to individual genetic backgrounds.

Published
2023
Full Text
View/download PDF

127. How to design high quality acupuncture trials—a consensus informed by evidence

Author

Zhang, Yu-Qing, Jiao, Rui-Min, Witt, Claudia M, Lao, Lixing, Liu, Jian-Ping, Thabane, Lehana, Sherman, Karen J, Cummings, Mike, Richards, Dawn P, Kim, Eun-Kyung Anna, Kim, Tae-Hun, Lee, Myeong Soo, Wechsler, Michael E, Brinkhaus, Benno, Mao, Jun J, Smith, Caroline A, Gang, Wei-Juan, Liu, Bao-Yan, Liu, Zhi-Shun, Liu, Yan, Zheng, Hui, Wu, Jia-Ni, Carrasco-Labra, Alonso, Bhandari, Mohit, Devereaux, Philip J, Jing, Xiang-Hong, Guyatt, Gordon, and University of Zurich

Subjects
10034 Institute of Complementary Medicine, Consensus, Acupuncture Therapy, Humans, Acupuncture, Guidance, 610 Medicine & health, Randomised controlled trials, General Medicine, Quality, RCT, Evidence
Published
2022

128. Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline

Author

Mao, Jun J; https://orcid.org/0000-0001-9229-0380, Ismaila, Nofisat; https://orcid.org/0000-0003-2074-1896, Bao, Ting; https://orcid.org/0000-0003-4437-2597, Barton, Debra; https://orcid.org/0000-0001-6624-3476, Ben-Arye, Eran; https://orcid.org/0000-0002-4058-3672, Garland, Eric L, Greenlee, Heather; https://orcid.org/0000-0003-4148-1405, Leblanc, Thomas; https://orcid.org/0000-0002-0546-7895, Lee, Richard T; https://orcid.org/0000-0001-9916-6155, Lopez, Ana Maria; https://orcid.org/0000-0002-2759-5353, Loprinzi, Charles; https://orcid.org/0000-0001-8044-5752, Lyman, Gary H; https://orcid.org/0000-0002-0823-8086, MacLeod, Jodi; https://orcid.org/0000-0002-3434-9011, Master, Viraj A, Ramchandran, Kavitha, Wagner, Lynne I; https://orcid.org/0000-0001-9685-4796, Walker, Eleanor M, Bruner, Deborah Watkins; https://orcid.org/0000-0002-5770-9948, Witt, Claudia M; https://orcid.org/0000-0002-5440-7805, Bruera, Eduardo; https://orcid.org/0000-0002-8745-0412, Mao, Jun J; https://orcid.org/0000-0001-9229-0380, Ismaila, Nofisat; https://orcid.org/0000-0003-2074-1896, Bao, Ting; https://orcid.org/0000-0003-4437-2597, Barton, Debra; https://orcid.org/0000-0001-6624-3476, Ben-Arye, Eran; https://orcid.org/0000-0002-4058-3672, Garland, Eric L, Greenlee, Heather; https://orcid.org/0000-0003-4148-1405, Leblanc, Thomas; https://orcid.org/0000-0002-0546-7895, Lee, Richard T; https://orcid.org/0000-0001-9916-6155, Lopez, Ana Maria; https://orcid.org/0000-0002-2759-5353, Loprinzi, Charles; https://orcid.org/0000-0001-8044-5752, Lyman, Gary H; https://orcid.org/0000-0002-0823-8086, MacLeod, Jodi; https://orcid.org/0000-0002-3434-9011, Master, Viraj A, Ramchandran, Kavitha, Wagner, Lynne I; https://orcid.org/0000-0001-9685-4796, Walker, Eleanor M, Bruner, Deborah Watkins; https://orcid.org/0000-0002-5770-9948, Witt, Claudia M; https://orcid.org/0000-0002-5440-7805, and Bruera, Eduardo; https://orcid.org/0000-0002-8745-0412

Abstract

Purpose: The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer. Methods: The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included pain intensity, symptom relief, and adverse events. Expert panel members used this evidence and informal consensus to develop evidence-based guideline recommendations. Results: The literature search identified 227 relevant studies to inform the evidence base for this guideline. Recommendations: Among adult patients, acupuncture should be recommended for aromatase inhibitor-related joint pain. Acupuncture or reflexology or acupressure may be recommended for general cancer pain or musculoskeletal pain. Hypnosis may be recommended to patients who experience procedural pain. Massage may be recommended to patients experiencing pain during palliative or hospice care. These recommendations are based on an intermediate level of evidence, benefit outweighing risk, and with moderate strength of recommendation. The quality of evidence for other mind-body interventions or natural products for pain is either low or inconclusive. There is insufficient or inconclusive evidence to make recommendations for pediatric patients. More research is needed to better characterize the role of integrative medicine interventions in the care of patients with cancer.Additional information is available at https://integrativeonc.org/practice-guidelines/guidelines and www.asco.org/survivorship-guidelines.

Published
2022

131. Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial

Author

Mao, Jun J., Xie, Sharon X., Zee, Jarcy, Soellera, Irene, Li, Qing S., Rockwell, Kenneth, and Amsterdam, Jay D.

Subjects
Major depressive disorder -- Analysis -- Care and treatment, Sertraline -- Comparative analysis, Biological sciences, Health, Science and technology
Abstract

ABSTRACT Background: We performed a proof of concept trial to evaluate relative safety and efficacy of Rhodiola rosea (R. rosea) versus sertraline for mild to moderate major depressive disorder. Hypothesis: [...]

Published
2015
Full Text
View/download PDF

134. How to design high quality acupuncture trials—a consensus informed by evidence

Author

Zhang, Yu-Qing, primary, Jiao, Rui-Min, additional, Witt, Claudia M, additional, Lao, Lixing, additional, Liu, Jian-Ping, additional, Thabane, Lehana, additional, Sherman, Karen J, additional, Cummings, Mike, additional, Richards, Dawn P, additional, Kim, Eun-Kyung Anna, additional, Kim, Tae-Hun, additional, Lee, Myeong Soo, additional, Wechsler, Michael E, additional, Brinkhaus, Benno, additional, Mao, Jun J, additional, Smith, Caroline A, additional, Gang, Wei-Juan, additional, Liu, Bao-Yan, additional, Liu, Zhi-Shun, additional, Liu, Yan, additional, Zheng, Hui, additional, Wu, Jia-Ni, additional, Carrasco-Labra, Alonso, additional, Bhandari, Mohit, additional, Devereaux, Philip J, additional, Jing, Xiang-Hong, additional, and Guyatt, Gordon, additional

Published
2022
Full Text
View/download PDF

135. Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy

Author

Daly, Bobby, primary, Nicholas, Kevin, additional, Flynn, Jessica, additional, Silva, Nicholas, additional, Panageas, Katherine, additional, Mao, Jun J., additional, Gazit, Lior, additional, Gorenshteyn, Dmitriy, additional, Sokolowski, Stefania, additional, Newman, Tiffanny, additional, Perry, Claire, additional, Wagner, Isaac, additional, Zervoudakis, Alice, additional, Salvaggio, Rori, additional, Holland, Jessie, additional, Chiu, Yeneat O., additional, Kuperman, Gilad J., additional, Simon, Brett A., additional, Reidy-Lagunes, Diane L., additional, and Perchick, Wendy, additional

Published
2022
Full Text
View/download PDF

138. Abstract P4-10-01: Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)

Author

Naughton, Michelle Joy, primary, Zahrieh, David, additional, Gnant, Michael, additional, Zdenkowski, Nicholas, additional, Lemieux, Julie, additional, Mao, Jun J, additional, Bjelic-Radisic, Vesna, additional, Shinn, Eileen, additional, Balic, Marija, additional, Thomssen, Christoph, additional, Neisel, Jane, additional, Ruiz-Echarri, Manuel, additional, Loibl, Sibylle, additional, Isaacs, Claudine, additional, Cameron, David, additional, Carrasco, Fernando Manuel Henao, additional, Goetz, Matthew, additional, Wette, Viktor, additional, Werutsky, Gustavo, additional, Rugo, Hope, additional, Vetter, Marcus, additional, Tseng, Ling-Ming, additional, Miller, Kathy, additional, Fitzal, Florian, additional, Gil, Juan Miguel Gil, additional, Park, Haeseong, additional, Linderholm, Barbro, additional, Bajetta, Emilio, additional, Dayao, Zoneddy, additional, Prat, Aleix, additional, Ehrhardt, Karin, additional, Metzger, Otto, additional, Arahmani, Amal, additional, Law, Ernest, additional, Partridge, Ann, additional, Carey, Lisa, additional, Zoroufy, Alex, additional, Dueck, Amylou, additional, Hlauschek, Dominik, additional, DeMichele, Angela, additional, and Mayer, Erica, additional

Published
2022
Full Text
View/download PDF

143. Assessment of Oncology Patient Engagement and Interest in Virtual Mind-Body Programming: Moving Toward Personalization of Virtual Care.

Author

Hung, Tony K. W., Latte-Naor, Shelly, Yuelin Li, Kuperman, Gilad J., Seluzicki, Christina, Pendleton, Eva, Pfister, David G., and Mao, Jun J.

Subjects
CANCER patient psychology, RESEARCH, PATIENT participation, CONFIDENCE intervals, MOTIVATION (Psychology), VIRTUAL reality, SELF-evaluation, MULTIPLE regression analysis, CROSS-sectional method, MATHEMATICAL models, INDIVIDUALIZED medicine, MEDICAL care, MACHINE learning, PATIENTS' attitudes, ONCOLOGY, SEX distribution, DESCRIPTIVE statistics, THEORY, RESEARCH funding, MIND & body therapies, SOCIODEMOGRAPHIC factors, RETIREMENT, ODDS ratio, NEEDS assessment, CANCER patient medical care
Abstract

PURPOSE Accelerated by the COVID-19 pandemic, the virtual platform has become a prominent medium to deliver mind-body therapies, but the extent to which patients engage in virtual mind-body programming remains unclear. This study aims to assess oncology patient engagement in a virtual mind-body program. METHODS We surveyed oncology patients enrolled in a live-streamed (synchronous) virtual mind-body program in May 2021. Patients self-reported engagement by weekly attendance. We applied multivariate regression to identify associations of engagement with sociodemographic and clinical factors. As an exploratory analysis, we used machine learning to partition engagement subgroups to determine preferential interest in prerecorded (asynchronous) mind-body therapy videos. RESULTS Among 148 patients surveyed (response rate: 21.4%), majority were female (94.5%), White (83.1%), age 65 years or older (64.9%), retired (64.2%), and in survivorship (61.8%). Patient engagement ranged from 1 to 13 classes/week (mean [standard deviation]: 4.23 [2.56]) and was higher for female (β .82; 95% CI, 0.01 to 1.62), non-White (β, .63; 95% CI, 0.13 to 1.13), and retired patients (β, .50; 95% CI, 0.12 to 0.88). The partition model identified three engagement subgroups: employed (low engagers), retired White (intermediate engagers), and retired non-White (high engagers). Particularly, low engagers had preferential interest in meditation videos (odds ratio, 2.85; 95% CI, 1.24 to 6.54), and both low and high engagers had preferential interest in Tai Chi videos (odds ratio, 2.26; 95% CI, 1.06 to 4.82). CONCLUSION In this cross-sectional study among oncology patients, engagement in virtual mind-body programming was higher for female, non-White, and retired patients. Our findings suggest the need for both synchronous and asynchronous mind-body programming to meet the diverse needs of oncology patients. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

144. Interest in and Barriers to Practicing Yoga among Family Caregivers of People with Cancer.

Author

Desai, Krupali, Applebaum, Allison J., Latte-Naor, Shelly, Pendleton, Eva M., Cheyney, Sarah, Li, Qing S., Ting Bao, Chimonas, Susan, and Mao, Jun J.

Abstract

Background: Family caregivers of people with cancer report high levels of psychological distress. Yoga, with well‑documented mental health benefits, could be a useful intervention to address distress in this population. However, little is known about yoga practices among cancer caregivers. The present study evaluates their interest in and barriers to yoga practice. Methods: We conducted a cross‑sectional survey study of family caregivers of cancer patients at five suburban satellite locations of an academic cancer center. Survey items and statistical analyses focused on yoga usage as well as interest in and barriers to yoga practice. Results: Among 539 participants, most were females (64.8%), white (84.2%), and caring for a spouse or partner (54.7%). Interest in practicing yoga among study participants was 42.3%. Increased interest was independently associated with being females (odds ratio [OR] = 3.30, 95% confidence interval [CI] = 1.98–5.51, P < 0.001) and employed (part‑time: OR = 2.58, 95% CI = 1.1–6.18, P = 0.03; full‑time: OR = 1.77, 95% CI = 1.1–2.01, P = 0.02). Few participants (6.3%) were currently practicing yoga, although 31% had done so in the past. Sixty‑one percent of those who had practiced before their loved one’s diagnosis stopped practicing yoga afterward. Commonly cited barriers to yoga practice included time constraints (37.3%) and psychological obstacles (33.6%). About a quarter of those who had never practiced yoga lacked awareness of yoga’s benefits (26.6%). Conclusion: Despite the low use of yoga, interest in practicing was moderately high, especially among women and employed caregivers. As caregivers face numerous barriers to yoga practice, strategies are needed to overcome these barriers and help them access yoga’s health benefits. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

147. Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Author

Mao, Jun J., primary, Pillai, Geetha Gopalakrishna, additional, Andrade, Carlos Jose, additional, Ligibel, Jennifer A., additional, Basu, Partha, additional, Cohen, Lorenzo, additional, Khan, Ikhlas A., additional, Mustian, Karen M., additional, Puthiyedath, Rammanohar, additional, Dhiman, Kartar Singh, additional, Lao, Lixing, additional, Ghelman, Ricardo, additional, Cáceres Guido, Paulo, additional, Lopez, Gabriel, additional, Gallego‐Perez, Daniel F., additional, and Salicrup, Luis Alejandro, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results